Evidence map›Paper›PMID 33498868›Full record

ReviewMolecules (Basel, Switzerland)2021

Acridine-Based Antimalarials-From the Very First Synthetic Antimalarial to Recent Developments.

Mélanie Fonte, Natália Tassi, Paula Gomes, Cátia Teixeira

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. EXCLI journal · 2024
    Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mélanie FonteLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, R. do Campo Alegre, 4169-007 Porto, Portugal.
Natália TassiLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, R. do Campo Alegre, 4169-007 Porto, Portugal.
Paula GomesLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, R. do Campo Alegre, 4169-007 Porto, Portugal.ORCID 0000-0002-6018-4724
Cátia TeixeiraLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, R. do Campo Alegre, 4169-007 Porto, Portugal.ORCID 0000-0001-9506-3781
Universidade do Porto · PT

Funding

Fundação para a Ciência e a Tecnologia UIDB/50006/2020, PTDC/BTM-SAL/29786/2017 and SFRH/BD/147345/2019
6 · The paper itself

Abstract

Malaria is among the deadliest infectious diseases in the world caused by

Indexed as

AcridinesAnimalsAntimalarialsHumansMalaria, FalciparumPlasmodium falciparumAcridinesAntimalarialsacridine derivativesantimalarialhybrid moleculesmalariaPlasmodium falciparumquinacrine

Identifiers

PMID33498868
PMCPMC7865557
OpenAlexW3124529332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.